Cargando…

Aurora Kinase Inhibitors: Current Status and Outlook

The Aurora kinase family comprises of cell cycle-regulated serine/threonine kinases important for mitosis. Their activity and protein expression are cell cycle regulated, peaking during mitosis to orchestrate important mitotic processes including centrosome maturation, chromosome alignment, chromoso...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bavetsias, Vassilios, Linardopoulos, Spiros
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2015
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4685048/ https://www.ncbi.nlm.nih.gov/pubmed/26734566 http://dx.doi.org/10.3389/fonc.2015.00278

Ejemplares similares

Metabolism of the dual FLT-3/Aurora kinase inhibitor CCT241736 in preclinical and human in vitro models: Implication for the choice of toxicology species
por: Wood, Francesca L., et al.
Publicado: (2019)

Aurora Isoform Selectivity: Design and Synthesis of Imidazo[4,5-b]pyridine Derivatives as Highly Selective Inhibitors of Aurora-A Kinase in Cells
por: Bavetsias, Vassilios, et al.
Publicado: (2013)

Optimization of Imidazo[4,5-b]pyridine-Based Kinase Inhibitors: Identification of a Dual FLT3/Aurora Kinase Inhibitor as an Orally Bioavailable Preclinical Development Candidate for the Treatment of Acute Myeloid Leukemia
por: Bavetsias, Vassilios, et al.
Publicado: (2012)

Aurora B prevents premature removal of spindle assembly checkpoint proteins from the kinetochore: A key role for Aurora B in mitosis
por: Gurden, Mark D., et al.
Publicado: (2016)

A Cell Biologist’s Field Guide to Aurora Kinase Inhibitors
por: de Groot, Christian O., et al.
Publicado: (2015)

7-(Pyrazol-4-yl)-3H-imidazo[4,5-b]pyridine-based derivatives for kinase inhibition: Co-crystallisation studies with Aurora-A reveal distinct differences in the orientation of the pyrazole N1-substituent
por: Bavetsias, Vassilios, et al.
Publicado: (2015)

Ubiquitin-Mediated Degradation of Aurora Kinases
por: Lindon, Catherine, et al.
Publicado: (2016)

Phenotypic Screening Approaches to Develop Aurora Kinase Inhibitors: Drug Discovery Perspectives
por: Marugán, Carlos, et al.
Publicado: (2016)

Unweaving the mitotic spindle: A focus on Aurora kinase inhibitors in lung cancer
por: Stefani, Alessio, et al.
Publicado: (2022)

Functions of Aurora kinase C in meiosis and cancer
por: Quartuccio, Suzanne M., et al.
Publicado: (2015)

Scientific Rationale Supporting the Clinical Development Strategy for the Investigational Aurora A Kinase Inhibitor Alisertib in Cancer
por: Niu, Huifeng, et al.
Publicado: (2015)

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and Lung Cancer: History, Epidemiology, and Market Outlook
por: Miles, Brittany, et al.
Publicado: (2021)

The Dawn of Aurora Kinase Research: From Fly Genetics to the Clinic
por: Carmena, Mar, et al.
Publicado: (2015)

Aurora-A Kinase as a Promising Therapeutic Target in Cancer
por: D’Assoro, Antonino B., et al.
Publicado: (2016)

Enhanced Cytotoxic Effects of Combined Valproic Acid and the Aurora Kinase Inhibitor VE465 on Gynecologic Cancer Cells
por: Li, Yanfang, et al.
Publicado: (2013)

Aurora Kinases and Potential Medical Applications of Aurora Kinase Inhibitors: A Review
por: Gavriilidis, Paschalis, et al.
Publicado: (2015)

The Aurora B Kinase in Chromosome Bi-Orientation and Spindle Checkpoint Signaling
por: Krenn, Veronica, et al.
Publicado: (2015)

Aurora Kinase A as a Diagnostic and Prognostic Marker of Malignant Mesothelioma
por: Guo, Zhenying, et al.
Publicado: (2021)

Corrigendum: Enhanced Cytotoxic Effects of Combined Valproic Acid and the Aurora Kinase Inhibitor VE465 on Gynecologic Cancer Cells
por: Li, Yanfang, et al.
Publicado: (2018)

Polo-like kinase-1, Aurora kinase A and WEE1 kinase are promising druggable targets in CML cells displaying BCR::ABL1-independent resistance to tyrosine kinase inhibitors
por: Mancini, Manuela, et al.
Publicado: (2022)

Functional Significance of Aurora Kinases–p53 Protein Family Interactions in Cancer
por: Sasai, Kaori, et al.
Publicado: (2016)

Synthesis and profiling of a 3-aminopyridin-2-one-based kinase targeted fragment library: Identification of 3-amino-5-(pyridin-4-yl)pyridin-2(1H)-one scaffold for monopolar spindle 1 (MPS1) and Aurora kinases inhibition
por: Fearon, Daren, et al.
Publicado: (2018)

Editorial: Aurora Kinases: Classical Mitotic Roles, Non-Canonical Functions and Translational Views
por: Pérez de Castro, Ignacio, et al.
Publicado: (2017)

Aurora-A expressing tumour cells are deficient for homology-directed DNA double strand-break repair and sensitive to PARP inhibition
por: Sourisseau, Tony, et al.
Publicado: (2010)

Helium: Current Status And Future Outlook
por: Fowler, W B
Publicado: (1990)

Targeting Aurora A Kinase (AAK) in Platinum-Resistant High Grade Serous Ovarian Cancer
por: Ganapathi, Ram N., et al.
Publicado: (2020)

Aurora kinase inhibitors: Progress towards the clinic
por: Kollareddy, Madhu, et al.
Publicado: (2012)

Opposing Effects of Inhibitors of Aurora-A and EGFR in Autosomal-Dominant Polycystic Kidney Disease
por: Nikonova, Anna S., et al.
Publicado: (2015)

Efficacy and Molecular Mechanisms of Differentiated Response to the Aurora and Angiogenic Kinase Inhibitor ENMD-2076 in Preclinical Models of p53-Mutated Triple-Negative Breast Cancer
por: Ionkina, Anastasia A., et al.
Publicado: (2017)

Adaptive designs: current status, future outlook
por: Grieve, Andy
Publicado: (2011)

Current Status and Future Outlook for Nonwovens in Japan
por: Yaida, Osamu
Publicado: (2016)

Current status and outlook of advances in exosome isolation
por: Liu, Wen-zhao, et al.
Publicado: (2022)

Tyrosine kinase inhibitors, ionic currents, and cardiac arrhythmia
por: Hu, Chi-Hao, et al.
Publicado: (2023)

Possible Role of Aurora-C in Meiosis
por: Yang, Kuo-Tai, et al.
Publicado: (2015)

Combined inhibition of MEK and Aurora A kinase in KRAS/PIK3CA double-mutant colorectal cancer models
por: Davis, S. Lindsey, et al.
Publicado: (2015)

Non-centrosomal TPX2-Dependent Regulation of the Aurora A Kinase: Functional Implications for Healthy and Pathological Cell Division
por: Garrido, Georgina, et al.
Publicado: (2016)

Exploration of the selective binding mechanism of protein kinase Aurora A selectivity via a comprehensive molecular modeling study
por: Zhang, Zhe, et al.
Publicado: (2019)

Low-dose antibiotics: current status and outlook for the future
por: Nosanchuk, Joshua D., et al.
Publicado: (2014)

Determination of Drugs in Clinical Trials: Current Status and Outlook
por: Tavana, Babak, et al.
Publicado: (2022)

Diffuse correlation spectroscopy: current status and future outlook
por: Carp, Stefan A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_dmd04s6vt1knojmrnont4s7dnf